Inhibrx Biosciences Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 1.44 M | $96.99 M | -0.69% | 9.32% |
| VIKING GLOBAL INVESTORS LP | 05/15/2026 | 1.44 M | $96.66 M | 0.00% | 9.28% |
| MORGAN STANLEY | 05/15/2026 | 1.26 M | $84.92 M | 8.17% | 8.16% |
| SANOFI | 05/07/2026 | 1.16 M | $77.85 M | 0.00% | 7.48% |
| HIGHTOWER ADVISORS, LLC | 05/05/2026 | 870.20 K | $58.50 M | -0.04% | 5.62% |
| BLACKROCK, INC. | 05/13/2026 | 798.90 K | $53.71 M | 2.77% | 5.16% |
| STATE STREET CORP | 05/15/2026 | 550.85 K | $37.03 M | 46.91% | 3.56% |
| 05/15/2026 | 486.42 K | $32.70 M | 100.00% | 3.14% | |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 406.03 K | $27.30 M | -10.70% | 2.62% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 05/13/2026 | 392.85 K | $26.41 M | -6.81% | 2.54% |
| WOODLINE PARTNERS LP | 05/15/2026 | 384.43 K | $25.85 M | 175.62% | 2.48% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 327.86 K | $22.04 M | 18.83% | 2.12% |
| PFM HEALTH SCIENCES, LP | 05/15/2026 | 305.43 K | $20.53 M | 15.03% | 1.97% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 254.83 K | $17.13 M | 18.68% | 1.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 231.51 K | $15.57 M | 2.43% | 1.49% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 05/14/2026 | 170.70 K | $11.48 M | -35.34% | 1.10% |
| SUMMITTX CAPITAL, L.P. | 05/15/2026 | 137.82 K | $9.27 M | 66.28% | 0.89% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 131.00 K | $8.81 M | 424.00% | 0.85% |
| 05/15/2026 | 125.00 K | $8.40 M | 100.00% | 0.81% | |
| 05/15/2026 | 124.53 K | $8.37 M | 12.38% | 0.80% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 97.87 K | $6.58 M | -67.06% | 0.63% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 95.07 K | $6.39 M | -5.51% | 0.61% |
| NORTHERN TRUST CORP | 05/14/2026 | 93.70 K | $6.30 M | 5.86% | 0.61% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 77.44 K | $5.21 M | -36.58% | 0.50% |
| KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2026 | 72.81 K | $4.90 M | 1.85% | 0.47% |
| 05/08/2026 | 72.46 K | $4.87 M | 100.00% | 0.47% | |
| DLD ASSET MANAGEMENT, LP | 05/13/2026 | 68.40 K | $4.60 M | -52.33% | 0.44% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 66.50 K | $4.47 M | 0.00% | 0.43% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 64.32 K | $4.32 M | 100.00% | 0.42% |
| CITIGROUP INC | 05/11/2026 | 62.52 K | $4.20 M | 12.12% | 0.40% |
| 05/15/2026 | 62.00 K | $4.17 M | 100.00% | 0.40% | |
| FMR LLC | 05/15/2026 | 52.81 K | $3.55 M | 14.13% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 52.80 K | $3.55 M | -57.79% | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 50.18 K | $3.37 M | -4.60% | 0.32% |
| UBS GROUP AG | 05/05/2026 | 48.14 K | $3.24 M | -34.68% | 0.31% |
| VOLEON CAPITAL MANAGEMENT LP | 05/15/2026 | 39.31 K | $2.64 M | 161.89% | 0.25% |
| JEFFERIES FINANCIAL GROUP INC. | 05/08/2026 | 38.97 K | $2.62 M | 337.85% | 0.25% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2026 | 35.18 K | $2.36 M | 0.00% | 0.23% |
| CITADEL ADVISORS LLC | 05/15/2026 | 34.40 K | $2.31 M | -21.46% | 0.22% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 34.21 K | $2.30 M | 16.72% | 0.22% |
| CITADEL ADVISORS LLC | 05/15/2026 | 33.16 K | $2.23 M | 23.26% | 0.21% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 32.68 K | $2.20 M | -52.71% | 0.21% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 32.54 K | $2.19 M | 119.12% | 0.21% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2026 | 30.98 K | $2.08 M | 100.00% | 0.20% |
| JUMP FINANCIAL, LLC | 05/14/2026 | 29.30 K | $1.97 M | 736.19% | 0.19% |
| CI PRIVATE WEALTH, LLC | 05/15/2026 | 28.81 K | $1.94 M | 40.95% | 0.19% |
| ATOM INVESTORS LP | 05/15/2026 | 26.51 K | $1.78 M | 100.00% | 0.17% |
| JANE STREET GROUP, LLC | 05/12/2026 | 26.20 K | $1.76 M | -29.19% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 25.87 K | $1.74 M | -3.27% | 0.17% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 25.79 K | $1.73 M | -9.19% | 0.17% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibrx Biosciences Inc. institutional Ownership - FAQ's
During the previous two years, 167 institutional investors and hedge funds held shares of Inhibrx Biosciences Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 1.44 M
VIKING GLOBAL INVESTORS LP: 1.44 M
MORGAN STANLEY: 1.26 M
Sanofi: 1.16 M
HighTower Advisors, LLC: 870,200
BlackRock, Inc.: 798,898
82.09% of Inhibrx Biosciences Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.59 M shares in the last 24 months. This purchase volume represents approximately $976.26 M in transactions.